Stocksigma LogoStocksigma Logo

AstraZeneca Pharma India Authorizes Key Managerial Personnel for Materiality Disclosures

AstraZeneca Pharma India Limited has updated its authorized Key Managerial Personnel under Regulation 30(5) of SEBI LODR Regulations, 2015, effective 9th

AstraZeneca Pharma India Authorizes Key Managerial Personnel for Materiality Disclosures

AstraZeneca Pharma India Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 11:40 pm

AstraZeneca Pharma India Authorizes Key Managerial Personnel for Materiality Disclosures AstraZeneca Pharma India Limited has updated its authorized Key Managerial Personnel under Regulation 30(5) of SEBI LODR Regulations, 2015, effective 9th Nov'26, for determining event materiality and stock exchange disclosures. The designated officials comprise Managing Director Praveen Rao Akkinepally, Chief Financial Officer Atul Tandon, and Company Secretary Tanya Sanish.

Original exchange filing (PDF)

More announcements from AstraZeneca Pharma India Ltd

All AstraZeneca Pharma India Ltd announcements